Lisa Costelloe

1.3k total citations
15 papers, 1.0k citations indexed

About

Lisa Costelloe is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Lisa Costelloe has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 3 papers in Neurology. Recurrent topics in Lisa Costelloe's work include Multiple Sclerosis Research Studies (7 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Polyomavirus and related diseases (2 papers). Lisa Costelloe is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Polyomavirus and related diseases (2 papers). Lisa Costelloe collaborates with scholars based in Ireland, United Kingdom and Australia. Lisa Costelloe's co-authors include Niall Tubridy, Róisín Lonergan, Katie Kinsella, Kingston H. G. Mills, Jean M. Fletcher, Cliona O’Farrelly, Barry Moran, Alasdair Coles, Joanne Jones and Michael Hutchinson and has published in prestigious journals such as The Journal of Immunology, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Lisa Costelloe

14 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa Costelloe Ireland	11	485	483	191	137	134	15	1.0k
Emiko Takahashi Japan	16	159 0.3×	424 0.9×	410 2.1×	102 0.7×	166 1.2×	74	958
Giorgia Teresa Maniscalco Italy	15	438 0.9×	447 0.9×	159 0.8×	94 0.7×	195 1.5×	64	1.1k
Nicolas Molnarfi Switzerland	21	941 1.9×	502 1.0×	240 1.3×	126 0.9×	151 1.1×	30	1.5k
Boli Fan Canada	5	705 1.5×	571 1.2×	152 0.8×	163 1.2×	167 1.2×	6	1.1k
Yusei Miyazaki Japan	18	840 1.7×	857 1.8×	157 0.8×	197 1.4×	414 3.1×	65	1.6k
A Helwig Germany	9	260 0.5×	233 0.5×	154 0.8×	80 0.6×	54 0.4×	21	698
Davide Vacirca Italy	18	225 0.5×	130 0.3×	244 1.3×	178 1.3×	47 0.4×	45	1.1k
Sterling Ortega United States	17	937 1.9×	402 0.8×	136 0.7×	73 0.5×	120 0.9×	33	1.4k
Gábor Gyülvészi Switzerland	8	1.1k 2.2×	236 0.5×	233 1.2×	83 0.6×	32 0.2×	9	1.4k
Melissa Padovan Italy	18	468 1.0×	163 0.3×	77 0.4×	773 5.6×	217 1.6×	45	1.3k

Countries citing papers authored by Lisa Costelloe

Since Specialization

Citations

This map shows the geographic impact of Lisa Costelloe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Costelloe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Costelloe more than expected).

Fields of papers citing papers by Lisa Costelloe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Costelloe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Costelloe. The network helps show where Lisa Costelloe may publish in the future.

Co-authorship network of co-authors of Lisa Costelloe

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Costelloe. A scholar is included among the top collaborators of Lisa Costelloe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Costelloe. Lisa Costelloe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Reilly, Thomas, et al.. (2024). The NLRP3 inflammasome: A central player in multiple sclerosis. Biochemical Pharmacology. 232. 116667–116667. 1 indexed citations

Costelloe, Lisa, et al.. (2022). Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis. Molecules. 27(6). 1763–1763. 8 indexed citations

Perry, Christopher J., Yann Desfougères, Lisa Costelloe, et al.. (2020). Phytocannabinoid‐dependent mTORC1 regulation is dependent upon inositol polyphosphate multikinase activity. British Journal of Pharmacology. 178(5). 1149–1163. 16 indexed citations

Nicholson, Patrick, et al.. (2017). Longitudinally extensive transverse myelitis after Campylobacter jejuni enteritis. Practical Neurology. 18(2). 143–145. 3 indexed citations

Tuohy, Orla, Lisa Costelloe, Grant Hill-Cawthorne, et al.. (2014). Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy. Journal of Neurology Neurosurgery & Psychiatry. 86(2). 208–215. 176 indexed citations

Byrne, Susan, Lisa Costelloe, Harry V. Vinters, et al.. (2014). Familial Cerebral Amyloid Angiopathy Due to the Iowa Mutation in an Irish Family. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 41(4). 512–517. 11 indexed citations

Costelloe, Lisa, Joanne Jones, & Alasdair Coles. (2012). Secondary autoimmune diseases following alemtuzumab therapy for multiple sclerosis. Expert Review of Neurotherapeutics. 12(3). 335–341. 79 indexed citations

Sweeney, Cheryl, Róisín Lonergan, Sharee A. Basdeo, et al.. (2011). IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells. Brain Behavior and Immunity. 25(6). 1170–1181. 108 indexed citations

Lonergan, Róisín, Lisa Costelloe, Killian O’Rourke, et al.. (2010). OAS1. Neurology. 75(5). 411–418. 21 indexed citations

10.

Fletcher, Jean M., Róisín Lonergan, Lisa Costelloe, et al.. (2009). CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis. The Journal of Immunology. 183(11). 7602–7610. 397 indexed citations

11.

Lonergan, Róisín, Michael J. Carr, Cillian De Gascun, et al.. (2009). Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy. Journal of NeuroVirology. 15(5-6). 351–359. 14 indexed citations

12.

Lonergan, Róisín, M. H. Carr, Cillian De Gascun, et al.. (2009). Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy. Journal of NeuroVirology. 1–9.

13.

Costelloe, Lisa, Alan J. Thompson, Cathal Walsh, Niall Tubridy, & Michael Hutchinson. (2008). Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease. Journal of Neurology Neurosurgery & Psychiatry. 79(11). 1245–1248. 44 indexed citations

14.

Costelloe, Lisa, Killian O’Rourke, Hugh Kearney, et al.. (2007). The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical). Journal of Neurology Neurosurgery & Psychiatry. 78(8). 841–844. 110 indexed citations

15.

Costelloe, Lisa, Killian O’Rourke, Christopher McGuigan, et al.. (2007). The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite. Multiple Sclerosis Journal. 14(2). 255–258. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact